Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    11790632 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting 18-Month Study of Curcumin
Conditions: Age-associated Cognitive Impairment;   Mild Cognitive Impairment (MCI)
Interventions: Drug: Curcumin;   Other: Placebo
2 Completed Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in the Dementia of Parkinson's Disease
Conditions: Parkinson's Disease;   Parkinson-Dementia Syndrome
Intervention: Other: [F18]-FDDNP

Indicates status has not been verified in more than two years